Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
493M
-
Number of holders
-
427
-
Total 13F shares, excl. options
-
433M
-
Shares change
-
+5.7M
-
Total reported value, excl. options
-
$12.7B
-
Value change
-
+$163M
-
Put/Call ratio
-
1.82
-
Number of buys
-
233
-
Number of sells
-
-165
-
Price
-
$29.45
Significant Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q1 2021
521 filings reported holding ELAN - Elanco Animal Health Inc - COMMON STOCK as of Q1 2021.
Elanco Animal Health Inc - COMMON STOCK (ELAN) has 427 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 433M shares
of 493M outstanding shares and own 87.75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (42.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (41.8M shares), PRIMECAP MANAGEMENT CO/CA/ (31.6M shares), JANUS HENDERSON GROUP PLC (28.2M shares), Sachem Head Capital Management LP (27.8M shares), Aristotle Capital Management, LLC (27.6M shares), WELLINGTON MANAGEMENT GROUP LLP (19.8M shares), STATE STREET CORP (14.2M shares), AMUNDI ASSET MANAGEMENT US, INC. (13.1M shares), and KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (9.31M shares).
This table shows the top 427 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.